HIV News and Research

RSS
Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Study: Chickenpox vaccination increases incidence of shingles in younger adults

Study: Chickenpox vaccination increases incidence of shingles in younger adults

New Johns Hopkins study shows hepatitis C infection may spell heart trouble

New Johns Hopkins study shows hepatitis C infection may spell heart trouble

Sexting, Internet safety climb higher on list of major health concerns for children

Sexting, Internet safety climb higher on list of major health concerns for children

More marijuana dispensaries associated with more marijuana-related hospitalization rates

More marijuana dispensaries associated with more marijuana-related hospitalization rates

Mylan announces launch of Lidocaine Patch 5% in the U.S.

Mylan announces launch of Lidocaine Patch 5% in the U.S.

CRI to honor three scientists for contributions to immunology and cancer immunotherapy research

CRI to honor three scientists for contributions to immunology and cancer immunotherapy research

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

Abusive and controlling men more likely to put female partners at sexual risk

Abusive and controlling men more likely to put female partners at sexual risk

Antiva raises $16 million in Series B financing to advance antiviral compound through Phase 1 clinical trials

Antiva raises $16 million in Series B financing to advance antiviral compound through Phase 1 clinical trials

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Hetero Group launches biosimilar 'Rituximab' under brand name MABALL in India

Hetero Group launches biosimilar 'Rituximab' under brand name MABALL in India

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

Nonmedical use of prescription opioids increasing among young adults

Nonmedical use of prescription opioids increasing among young adults

Researchers reveal how insulin reaches and acts in the brain to improve memory

Researchers reveal how insulin reaches and acts in the brain to improve memory

University of Liverpool study finds that HIV can continue to grow in patients despite treatment

University of Liverpool study finds that HIV can continue to grow in patients despite treatment

Genotype A HBV mapped in acute, chronic Japanese patients

Genotype A HBV mapped in acute, chronic Japanese patients

New article explains why animal models are still essential to biological research

New article explains why animal models are still essential to biological research

Northwestern gets $17.5 million NIH grant to invent, develop implantable drug delivery system for HIV prevention

Northwestern gets $17.5 million NIH grant to invent, develop implantable drug delivery system for HIV prevention

Pitt investigators to lead $5 million initiative to monitor resistance to HIV prevention drugs in sub-Saharan Africa

Pitt investigators to lead $5 million initiative to monitor resistance to HIV prevention drugs in sub-Saharan Africa

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.